KALV
Kalvista Pharmaceuticals Inc
Price:
15.39
USD
Volume:
1,279,125
United States | Biotechnology
KALV Probability of Bankruptcy
The Probability of Bankruptcy of Kalvista Pharmaceuticals Inc (KALV) is 5.3% . This number represents the probability that KALV will face financial distress in the next 24 months given its current fundamentals and market conditions.
Multiple factors are taken into account when calculating KALV's probability of bankruptcy : Altman Z-score, Beneish M-score, financial position, macro environments, academic research about distress risk and more.
KALV - Historical Solvency Measures
to of
Page of
KALV - ESG ratings
ESG ratings are directly linked to the cost of capital and KALV's ability to raise funding, both of which can significantly affect the probability of Kalvista Pharmaceuticals Inc going bankrupt.
ESG Score
51.72
Environment Score
53.47
Social Score
70.53
Governance Score
31.18
| Returns | |
| Historical Returns (5 day) | 4.95% |
| Historical Returns (MTD) | 20.42% |
| Historical Returns (YTD) | 67.77% |
| Historical Returns (13 week) | 18.52% |
| Historical Returns (26 week) | 38.36% |
| Historical Returns (52 week) | 21.66% |
| Efficiency | |
| Asset Turnover | 0.12 |
| Receiveable Turnover | - |
| Gross Margin | - |
| Operating Margin | - |
| Pretax Margin | - |
| Net Margin | - |
| Return on Asset (ROA) | -88.06 |
| Return on Equity (ROE) | -103.92 |
| Return on Investments (ROI) | -103.92 |
| Price Metrics | |
| Market Cap (M) | 765.2 |
| Enterprise Value (M) | 739.5 |
| 52 Week High | 15.5 |
| 52 Week Low | 7.3 |
| Beta | 0.1 |
| Average Volume (10 day) | 0.62 |
| Average Volume (3 month) | 0.57 |
| Price / Earnings (P/E) | - |
| Price / Sales (P/S) | 54 |
| Earnings | |
| EPS | -3.64 |
| Revenue CAGR (5 year) | - |
| Risk | |
| Current Ratio | 10.44 |
| Quick Ratio | 10.25 |